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A common theme in the Symposium is that the 
identification of defective genes in hereditary neuro-
logical disease can give new insight into basic mech-
anisms of cellular structure and function. This paper 
deals with the genetic defect responsible for the X-
linked form of Charcot-Marie-Tooth disease. 
X-LINKED CHARCOT-MARIE-TOOTH DISEASE 
AND CONNEXIN32 
Charcot-Marie-Tooth disease (CMT) causes pro-
gressive weakness, atrophy, and sensory loss in the 
feet, lower legs, and hands. Overall, CMT is a relative-
ly common hereditary disorder, affecting about 1 in 
2500 individuals, more than 100,000 Americans. The 
cause of the manifestations of CMT is degeneration 
of the peripheral nerves. In different families, the 
degenerative process can affect the axons, the myelin, 
or both. 
CMT is genetically heterogeneous. It is classified 
first according to whether the pathology is primarily 
demyelinative or axonal, and second according to the 
specific genetic defect (Chance and Fischbeck 1994). 
The most common form, CMT1A, and a less common 
form, CMT1B, are caused by defects in the genes for 
myelin proteins PMP22 and P0, respectively. The X-
linked form of the disease (CMTX) is caused by muta-
tions in the gap junction protein, connexin32 (Bergof-
fenetal. 1993b). 
CMTX accounts for about 10% of patients with 
CMT and is probably the second most common cause 
of hereditary neuropathy after CMT1A. It is most 
often considered an X-linked dominant disease (Fisch-
beck et al. 1990; Deschenes et al. 1996). The disease is 
commonly passed from generation to generation, af-
fecting both males and females as with autosomal dom-
inant transmission, except that there is no father-to-son 
transmission. Heterozygous females are variably in-
volved and in some families may be asymptomatic. 
Nerve conduction velocities tend to be slow, in an in-
termediate range, and nerve biopsies may show signs 
of both demyelination and axonal degeneration. 
Several years ago, we and other workers set out to 
identify the CMTX disease gene by positional cloning, 
and the disease locus was eventually narrowed to a 
small segment of the proximal long arm of the X 
chromosome, at Xql3.1 (Bergoffen et al. 1993a). The 
interval to which CMTX was mapped contained three 
previously identified genes, including the gene for con-
nexin32. We evaluated connexin32 as a candidate gene, 
first by determining whether or not it is expressed in 
peripheral nerve. Northern blots show that connexin32 
is expressed in peripheral nerve, and that it follows the 
same pattern of expression as other myelin-related 
genes, decreasing in nerve that is degenerating after 
transection and increasing in nerve that is regenerating 
after a crush (Scherer et al. 1995). This pattern differs 
from that of nerve growth factor receptor and the 
housekeeping gene glyceraldehyde phosphate dehy-
drogenase. In cultured Schwann cells, connexin32 is ex-
pressed with other myelin genes when the cells are 
treated with forskolin, an agent that increases cAMP 
levels. 
Connexin32 is encoded by a relatively simple gene 
with two promoters, and the translated sequence is 
contained in a single exon (Fig. 1). The first promoter, 
PI, drives expression in the liver, where connexin32 
was first identified, and elsewhere in the body. The sec-
ond promoter, P2, is nervous-system-specific and 
drives expression in peripheral nerve in a pattern 
similar to other myelin genes. Once we knew that the 
connexin32 gene is expressed in peripheral nerve and 
mapped to the same location as CMTX on the X 
chromosome, we set out to look for mutations in 
CMTX patients. We found that the large majority of 
CMTX patients have mutations in the translated por-
tion of the gene (Bone et al. 1995). Since 1993, over 70 
different mutations have been identified. 
Many of the known CMTX mutations are shown in 
Figure 2, where connexin32 is shown in its likely topo-
graphic orientation, as an integral membrane protein 
with four transmembrane domains and amino and car-
boxyl termini within the cell. There are two ex-
tracellular loops with highly conserved cysteine 
residues that are thought to be involved in in-
tramolecular disulfide bonds that ultimately stabilize 
mourn \-
exon 2 
Figure 1. Structure of the human connexin32 gene. (ORF) 
Open reading frame. 
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Figure 2. Diagram showing the topographic orientation of connexin32 with the locations of known CMTX mutations. 74 different 
mutations have been identified in 91 families. 
the gap junction structure. The transmembrane 
domains are also highly conserved across species and 
among different members of the connexin gene family. 
The CMTX mutations are mostly missense (amino acid 
substitutions), although deletions, frameshifts, and 
premature stop mutations are also seen. Mutations 
have been found in every portion of the protein. 
CONNEXIN32 STRUCTURE AND FUNCTION 
Connexin32, like other members of the connexin 
family, is a channel protein. Six identical subunits 
cluster in the plasma membrane to form a hemichannel 
or connexon. This structure docks with a similar struc-
ture in another membrane to form a complete channel. 
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The channel has a central pore that allows passage of 
ions and other small molecules up to 1000 daltons in 
size from one cell to another. An array of individual 
channels makes up a gap junction. 
Connexin32 is found in a variety of cells and tissues, 
including liver, secretory epithelium, and brain. Until it 
was implicated in CMTX, connexin32 was not known 
to be expressed in peripheral nerve, nor were gap junc-
tions known to play a role in peripheral nerve structure 
and function. 
What effect do the CMTX mutations have on the 
function of connexin32? Roberto Bruzzone in David 
Paul's laboratory at Harvard addressed this question 
by introducing wild-type and mutant connexin32 into 
Xenopus oocytes and assaying the formation of gap 
junctions electrophysiologically (Bruzzone et al. 1994). 
Normal connexin32, but not mutant connexin32, forms 
functional gap junctions in this system. Furthermore, 
mutant connexin32 interferes with the formation of 
gap junctions by co-injected wild-type cDNA, suggest-
ing a dominant-negative effect. 
INTRACELLULAR TRAFFICKING OF MUTANT 
CONNEXIN32 
We have gone on to investigate the fate of mutant 
connexin32 in stably transfected mammalian (PC12J) 
Figure 4. Teased fiber preparation of rat sciatic nerve, show-
ing immunofluorescent staining of connexin32 at nodes of 
Ranvier and Schmidt-Lanterman incisures. 
cells. Here the wild-type connexin32 protein forms ag-
gregates at points of cell-cell contact (Fig. 3A). These 
are not seen in nontransfected cells. Immunohisto-
chemistry of cells transfected with connexin32 cDNA 
derived from a CMTX patient shows that the mutant 
protein "hangs up" in the cytoplasm, most prominently 
in the endoplasmic reticulum and Golgi apparatus, and 
is not properly routed to the plasma membrane (Fig. 
3B). 
Figure 3. Immunofluorescence of connexin32 in stably trans-
fected PC12J cells. (A) Wild-type connexin32, which localizes 
to the plasma membrane at points of cell-cell contact. (B) 
Mutant connexin32, which remains in the cytoplasm. 
Figure 5. Confocal image of myelinated nerve fibers showing 
immunofluorescent staining of PQ (green) and connexin32 
(orange). 
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Figure 6. Schematic diagram of myelinated nerve, with the Schwann cell "unwound." Shown are the relative distributions of con-
nexin32 and other myelin proteins and the location of putative gap junctions. 
We have looked at seven different mutations and 
have found different effects on intracellular trafficking. 
In one case, the mutant cDNA is expressed at the 
mRNA but not the protein level; perhaps this protein 
is degraded too rapidly to give signal by immuno-
fluorescence and Western blot. In several cases, some 
plasma membrane signal is seen. However, with most 
mutations, particularly those affecting residues within 
and adjacent to the transmembrane domains, the pro-
tein accumulates in the cytoplasm. It may be that mis-
routed connexin32 protein has a toxic effect on 
Schwann cells and axons, beyond the direct effects of 
loss of the protein's function. We plan to sort out toxic 
or dominant-negative effects in vivo by studying trans-
genic mice. 
We are using transgenic constructs with the P0 
promoter to introduce two different mutant forms of 
connexin32 into mice. These mice are being bred with 
connexin32 knockout mice to observe the effects of the 
mutations on a null background. The knockout mice 
were produced by Dr. Klaus Willecke in Bonn, and 
have a relatively mild phenotype, consistent with a 
dominant-negative or toxic effect of the mutant protein 
on peripheral nerve. 
CONNEXIN32 FUNCTION IN NORMAL NERVE 
What is connexin32 doing in peripheral nerve? We 
can begin to answer that question by looking to see 
where connexin32 is normally located. We have done 
immunohistochemistry and have found connexin32 to 
be present in noncompacted myelin around the nodes 
of Ranvier and at Schmidt-Lanterman incisures 
(Bergoffen et al. 1993b; Scherer et al. 1995). This is a 
different distribution from other proteins implicated in 
hereditary neuropathy, PMP22 and P0, which are lo-
cated in compact myelin. The incisures and paranodes 
where connexin32 is located are residual folds of non-
compacted Schwann cell cytoplasm that remain after 
the Schwann cell wraps itself around the axon to form 
the myelin sheath. 
Figure 4 shows a teased fiber preparation demon-
strating connexin32 staining in noncompacted myelin 
at the nodes and incisures. Figure 5 is a confocal image 
of myelinated nerve fibers with P0 stained green in the 
compact myelin, and connexin32 stained orange at the 
node of Ranvier. There is no overlap between the dis-
tributions of P0 and connexin32. Figure 6 shows the 
locations of connexin32 and other myelin proteins in 
peripheral nerve. David Paul proposed that con-
nexin32 forms "reflexive" gap junctions at these sites, 
connecting different parts of the same Schwann cell 
rather than two different cells, and forming a path for 
diffusion of ions and other small molecules across the 
myelin sheath. This path perhaps provides nutritional 
support to the innermost layers of Schwann cell cyto-
plasm and indirectly to the axon, as well. 
Preliminary results with injection of different dyes 
into myelinating Schwann cells of peripheral nerve in-
dicate that such a path does indeed exist (R. Balice-
Gordon et al., unpubl.). Low-molecular-weight dyes 
pass rapidly through incisures to the inner layers of 
Schwann cell cytoplasm, whereas high-molecular-
weight dyes do not. We suspect that a loss of this path-
way and perhaps additional toxic effects of misrouted 
protein account for the myelin loss and axonal degen-
eration of X-linked Charcot-Marie-Tooth disease. 
The connexin32-CMTX story demonstrates how, 
when the interests of basic research and clinical medi-
cine are coincident, we are brought to a better under-
standing not only of disease mechanisms, but also of 
the essentials of normal nervous system structure and 
function. 
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